{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:31:05Z","timestamp":1794490265854,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":102,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High-level Talents Program of Xi'an International University","award":["XAIU202201"],"award-info":[{"award-number":["XAIU202201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03191-3","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:32:39Z","timestamp":1777793559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The association between triglyceride glucose-frailty index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xinjiang","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guaijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"key":"3191_CR1","doi-asserted-by":"publisher","first-page":"102991","DOI":"10.1016\/j.arr.2025.102991","volume":"114","author":"L Yang","year":"2026","unstructured":"Yang L, Zhang Z, Zhang J, Miao J, Zhang H, Du Y, et al. Stage-specific risk factors of cardiometabolic multimorbidity: a systematic review and meta-analysis from incidence to mortality. Ageing Res Rev. 2026;114:102991. https:\/\/doi.org\/10.1016\/j.arr.2025.102991.","journal-title":"Ageing Res Rev"},{"key":"3191_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. 2025;24:257. https:\/\/doi.org\/10.1186\/s12933-025-02819-0.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR3","doi-asserted-by":"publisher","first-page":"e024476","DOI":"10.1136\/bmjopen-2018-024476","volume":"9","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang X, Shen P, Si Y, Liu X, Xu Z, et al. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study. BMJ Open. 2019;9:e024476. https:\/\/doi.org\/10.1136\/bmjopen-2018-024476.","journal-title":"BMJ Open"},{"key":"3191_CR4","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41591-025-04038-2","volume":"32","author":"AM Ornago","year":"2026","unstructured":"Ornago AM, Gregorio C, Triolo F, Moore AZ, Marengoni A, Beridze G, et al. Shared and specific blood biomarkers for multimorbidity. Nat Med. 2026;32:736\u201345. https:\/\/doi.org\/10.1038\/s41591-025-04038-2.","journal-title":"Nat Med"},{"key":"3191_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s41043-026-01307-9","author":"Y Pan","year":"2026","unstructured":"Pan Y, Bi J, Feng L, He X. Association of a novel triglyceride-glucose and non-HDL-to-HDL cholesterol ratio (TyG-NHHR) index with cardiometabolic multimorbidity: a dual-cohort prospective study in Chinese and European adults. J Health Popul Nutr. 2026. https:\/\/doi.org\/10.1186\/s41043-026-01307-9.","journal-title":"J Health Popul Nutr"},{"key":"3191_CR6","doi-asserted-by":"publisher","first-page":"1381949","DOI":"10.3389\/fendo.2024.1381949","volume":"15","author":"X Ye","year":"2024","unstructured":"Ye X, Zhang G, Han C, Wang P, Lu J, Zhang M. The association between Chinese visceral adiposity index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national cohort study. Front Endocrinol (Lausanne). 2024;15:1381949. https:\/\/doi.org\/10.3389\/fendo.2024.1381949.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3191_CR7","doi-asserted-by":"publisher","first-page":"1511319","DOI":"10.3389\/fendo.2025.1511319","volume":"16","author":"B Wan","year":"2025","unstructured":"Wan B, Wang S, Hu S, Han W, Qiu S, Zhu L, et al. The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic multimorbidity. Front Endocrinol (Lausanne). 2025;16:1511319. https:\/\/doi.org\/10.3389\/fendo.2025.1511319.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3191_CR8","doi-asserted-by":"publisher","first-page":"42139","DOI":"10.1038\/s41598-025-25958-6","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Fan M, Yang M, Huang W, Shi W, Zhang D, et al. Remnant cholesterol and body mass index jointly associate with cardiometabolic multimorbidity with mediation analysis in CHARLS a prospective cohort study. Sci Rep. 2025;15:42139. https:\/\/doi.org\/10.1038\/s41598-025-25958-6.","journal-title":"Sci Rep"},{"key":"3191_CR9","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1038\/s41467-024-46686-x","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhuang Z, Li Y, Xiao W, Song Z, Huang N, et al. Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity. Nat Commun. 2024;15:2451. https:\/\/doi.org\/10.1038\/s41467-024-46686-x.","journal-title":"Nat Commun"},{"key":"3191_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/00325481.2025.2510894","volume":"137","author":"Y Gao","year":"2025","unstructured":"Gao Y, Li Y, Zhang Y, Jiang H. Treatment burden and its impact on residual cardiovascular risk in community-dwelling older adults with cardiometabolic multimorbidity: an exploratory cross-sectional study. Postgrad Med. 2025;137:396\u2013403. https:\/\/doi.org\/10.1080\/00325481.2025.2510894.","journal-title":"Postgrad Med"},{"key":"3191_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12933-025-03067-y","volume":"25","author":"H Lai","year":"2026","unstructured":"Lai H, Deng C, Liao C, Tian R, Liu K, Luo Z, et al. Joint assessment of insulin resistance surrogate indices and basal metabolic rate for primary prevention of cardiometabolic multimorbidity: evidence from the China health and retirement longitudinal study (2011\u20132020). Cardiovasc Diabetol. 2026;25:37. https:\/\/doi.org\/10.1186\/s12933-025-03067-y.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-03022-x","volume":"25","author":"G Santulli","year":"2025","unstructured":"Santulli G, Sabatelli G, Wang B, Savino M, Bruno FP, Jankauskas SS, et al. Interplay between frailty and cardiometabolic disorders: from pathophysiology to clinical implications. Cardiovasc Diabetol. 2025;25:1. https:\/\/doi.org\/10.1186\/s12933-025-03022-x.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR13","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1093\/eurheartj\/ehab413","volume":"42","author":"Y Han","year":"2021","unstructured":"Han Y, Hu Y, Yu C, Guo Y, Pei P, Yang L, et al. Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study. Eur Heart J. 2021;42:3374\u201384. https:\/\/doi.org\/10.1093\/eurheartj\/ehab413.","journal-title":"Eur Heart J"},{"key":"3191_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12933-025-02980-6","volume":"24","author":"K Qu","year":"2025","unstructured":"Qu K, Dal Canto E, van Ommen A-MLN, Kamar SA, Teske AJ, Cramer MJ, et al. Proteome organ aging and cardiometabolic risk in a population at risk for heart failure. Cardiovasc Diabetol. 2025;24:430. https:\/\/doi.org\/10.1186\/s12933-025-02980-6.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2024.08.026","volume":"131","author":"Y Sun","year":"2025","unstructured":"Sun Y, Ji H, Sun W, An X, Lian F. Triglyceride glucose (TyG) index: a promising biomarker for diagnosis and treatment of different diseases. Eur J Intern Med. 2025;131:3\u201314. https:\/\/doi.org\/10.1016\/j.ejim.2024.08.026.","journal-title":"Eur J Intern Med"},{"key":"3191_CR16","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.chest.2021.03.056","volume":"160","author":"TD Wu","year":"2021","unstructured":"Wu TD, Fawzy A, Brigham E, McCormack MC, Rosas I, Villareal DT, et al. Association of triglyceride-glucose index and lung health. Chest. 2021;160:1026\u201334. https:\/\/doi.org\/10.1016\/j.chest.2021.03.056.","journal-title":"Chest"},{"key":"3191_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-025-02716-6","volume":"24","author":"Z Song","year":"2025","unstructured":"Song Z, Miao X, Liu S, Hu M, Xie X, Sun Y, et al. Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study. Cardiovasc Diabetol. 2025;24:1\u201312. https:\/\/doi.org\/10.1186\/s12933-025-02716-6.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-025-02587-x","volume":"24","author":"J Liu","year":"2025","unstructured":"Liu J, Fu Y, Liang P, Song Z, Li Y, Wu H. The association between novel metabolic parameters and all-cause\/cardiovascular mortality in patients with metabolic syndrome is modified by age. Cardiovasc Diabetol. 2025;24:1\u201312. https:\/\/doi.org\/10.1186\/s12933-025-02587-x.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21:1\u201317. https:\/\/doi.org\/10.1186\/s12933-022-01546-0.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-024-02446-1","volume":"23","author":"S Tao","year":"2024","unstructured":"Tao S, Yu L, Li J, Huang L, Xue T, Yang D, et al. Multiple triglyceride-derived metabolic indices and incident cardiovascular outcomes in patients with type 2 diabetes and coronary heart disease. Cardiovasc Diabetol. 2024;23:1\u201311. https:\/\/doi.org\/10.1186\/s12933-024-02446-1.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR21","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1007\/s11357-023-01044-5","volume":"46","author":"SK Kunutsor","year":"2024","unstructured":"Kunutsor SK, Seidu S, Kurl S, Laukkanen JA. Baseline and usual triglyceride-glucose index and the risk of chronic kidney disease: a prospective cohort study. GeroScience. 2024;46:3035\u201346. https:\/\/doi.org\/10.1007\/s11357-023-01044-5.","journal-title":"GeroScience"},{"key":"3191_CR22","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/dom.70270","volume":"28","author":"G Mavraganis","year":"2025","unstructured":"Mavraganis G, Georgiopoulos G, Athanasopoulos S, Terentes-Printzios D, Zervas G, Konstantaki C, et al. Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose index. Diabetes Obes Metab. 2025;28:982\u201393. https:\/\/doi.org\/10.1111\/dom.70270.","journal-title":"Diabetes Obes Metab"},{"key":"3191_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-025-02671-2","volume":"24","author":"M Sbriscia","year":"2025","unstructured":"Sbriscia M, Colombaretti D, Giuliani A, Di Valerio S, Scisciola L, Rusanova I, et al. Triglyceride glucose index predicts long-term mortality and major adverse cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2025;24:1\u201310. https:\/\/doi.org\/10.1186\/s12933-025-02671-2.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-025-02826-1","volume":"24","author":"J Liu","year":"2025","unstructured":"Liu J, Kang J, Liang P, Song Z, Li G, Jin X, et al. The association between triglyceride-glucose index and all-cause\/cardiovascular mortality in patients with different glucose metabolism statuses. Cardiovasc Diabetol. 2025;24:1\u201314. https:\/\/doi.org\/10.1186\/s12933-025-02826-1.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR25","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/s2666-7568(22)00247-1","volume":"4","author":"P Lopez-Jaramillo","year":"2022","unstructured":"Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, Abat MEM, Alhabib KF, Avezum \u00c1, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2022;4:e23-33. https:\/\/doi.org\/10.1016\/s2666-7568(22)00247-1.","journal-title":"Lancet Healthy Longev"},{"key":"3191_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-025-02574-2","volume":"24","author":"C Pavanello","year":"2025","unstructured":"Pavanello C, Ruscica M, Castiglione S, Mombelli GG, Alberti A, Calabresi L, et al. Triglyceride-glucose index: carotid intima-media thickness and cardiovascular risk in a European population. Cardiovasc Diabetol. 2025;24:1\u201312. https:\/\/doi.org\/10.1186\/s12933-025-02574-2.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR27","doi-asserted-by":"publisher","first-page":"111546","DOI":"10.1016\/j.mad.2021.111546","volume":"198","author":"AE Kane","year":"2021","unstructured":"Kane AE, Howlett SE. Sex differences in frailty: Comparisons between humans and preclinical models. Mech Ageing Dev. 2021;198:111546. https:\/\/doi.org\/10.1016\/j.mad.2021.111546.","journal-title":"Mech Ageing Dev"},{"key":"3191_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ageing\/afad221","volume":"52","author":"O Theou","year":"2023","unstructured":"Theou O, Haviva C, Wallace L, Searle SD, Rockwood K. How to construct a frailty index from an existing dataset in 10 steps. Age Ageing. 2023;52:1\u20137. https:\/\/doi.org\/10.1093\/ageing\/afad221.","journal-title":"Age Ageing"},{"key":"3191_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurjpc\/zwaf095","volume":"21","author":"AZZ Phyo","year":"2025","unstructured":"Phyo AZZ, Tonkin A, Espinoza SE, Vishwanath S, Murray AM, Woods RL, et al. Frailty trajectories after a cardiovascular event among community-dwelling older people. Eur J Prev Cardiol. 2025;21:119. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf095.","journal-title":"Eur J Prev Cardiol"},{"key":"3191_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cjca.2024.06.017","volume":"41","author":"DP Leong","year":"2025","unstructured":"Leong DP, Bosch J, Bhatt DL, Avezum A, Yuan F, Yusuf S, et al. Impact of frailty on the benefits of dual pathway inhibition for the secondary prevention of cardiovascular events in the COMPASS randomised trial. Can J Cardiol. 2025;41:102\u201311. https:\/\/doi.org\/10.1016\/j.cjca.2024.06.017.","journal-title":"Can J Cardiol"},{"key":"3191_CR31","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/jcsm.13047","volume":"13","author":"TJ Wilkinson","year":"2022","unstructured":"Wilkinson TJ, Miksza J, Zaccardi F, Lawson C, Nixon AC, Young HML, et al. Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2022;13:2426\u201335. https:\/\/doi.org\/10.1002\/jcsm.13047.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3191_CR32","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/eurheartj\/ehad885","volume":"45","author":"D He","year":"2024","unstructured":"He D, Wang Z, Li J, Yu K, He Y, He X, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J. 2024;45:1058\u201368. https:\/\/doi.org\/10.1093\/eurheartj\/ehad885.","journal-title":"Eur Heart J"},{"key":"3191_CR33","doi-asserted-by":"publisher","first-page":"112354","DOI":"10.1093\/ageing\/afaf309","volume":"226","author":"H Logan Ellis","year":"2025","unstructured":"Logan Ellis H, Rockwood K. Does predicting who will fall tomorrow tell you who is frail today? Age Ageing. 2025;226:112354. https:\/\/doi.org\/10.1093\/ageing\/afaf309.","journal-title":"Age Ageing"},{"key":"3191_CR34","doi-asserted-by":"publisher","first-page":"103875","DOI":"10.1016\/j.ijnurstu.2021.103875","volume":"117","author":"H Si","year":"2021","unstructured":"Si H, Jin Y, Qiao X, Tian X, Liu X, Wang C. Predictive performance of 7 frailty instruments for short-term disability, falls and hospitalization among Chinese community-dwelling older adults: a prospective cohort study. Int J Nurs Stud. 2021;117:103875. https:\/\/doi.org\/10.1016\/j.ijnurstu.2021.103875.","journal-title":"Int J Nurs Stud"},{"key":"3191_CR35","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/ggi.14647","volume":"23","author":"W Chu","year":"2023","unstructured":"Chu W, Ho H, Yeh C, Wei JC, Arai H, Lee M. Additive effect of frailty with distinct multimorbidity patterns on mortality amongst middle-aged and older adults in Taiwan: a 16-year population-based study. Geriatr Gerontol Int. 2023;23:684\u201391. https:\/\/doi.org\/10.1111\/ggi.14647.","journal-title":"Geriatr Gerontol Int"},{"key":"3191_CR36","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/jcsm.13197","volume":"14","author":"Y Luo","year":"2023","unstructured":"Luo Y, Chen Y, Wang K, De Fries CM, Huang Z, Xu H, et al. Associations between multimorbidity and frailty transitions among older Americans. J Cachexia Sarcopenia Muscle. 2023;14:1075\u201382. https:\/\/doi.org\/10.1002\/jcsm.13197.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3191_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41514-025-00301-5","volume":"12","author":"RH Zhang","year":"2025","unstructured":"Zhang RH, Wang J, Wang Y, Li RQ, Lu TY, Zhou BJ, et al. Frailty and transitions across cardiometabolic disease states: evidence from multistate models in a 16-year Chinese cohort. NPJ Aging. 2025;12:4. https:\/\/doi.org\/10.1038\/s41514-025-00301-5.","journal-title":"NPJ Aging"},{"key":"3191_CR38","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1093\/gerona\/glad125","volume":"78","author":"T Ma","year":"2023","unstructured":"Ma T, He L, Luo Y, Fu D, Huang J, Zhang G, et al. Frailty, an independent risk factor in progression trajectory of cardiometabolic multimorbidity: a prospective study of UK biobank. J Gerontol A Biol Sci Med Sci. 2023;78:2127\u201335. https:\/\/doi.org\/10.1093\/gerona\/glad125.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3191_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-025-02880-9","volume":"24","author":"C Diabetology","year":"2025","unstructured":"Diabetology C, Zhao Y-C, Wu S-Q, Yan M, Li J-K, Sun Z-H, et al. Predictive value of the combined triglyceride-glucose and frailty index for cardiovascular disease and stroke in two prospective cohorts. Cardiovasc Diabetol. 2025;24:1\u201315. https:\/\/doi.org\/10.1186\/s12933-025-02880-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR40","doi-asserted-by":"publisher","first-page":"112989","DOI":"10.1016\/j.diabres.2025.112989","volume":"230","author":"C Zhang","year":"2025","unstructured":"Zhang C, Chen Y, Wang T, Peng W, Ning M, Liu Y. Inflammation and abnormal glucose-lipid metabolism are critical for population stratification toward progressive frailty in cardiovascular-kidney-metabolic syndrome. Diabetes Res Clin Pract. 2025;230:112989. https:\/\/doi.org\/10.1016\/j.diabres.2025.112989.","journal-title":"Diabetes Res Clin Pract"},{"key":"3191_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-024-02241-y","volume":"23","author":"J-L Yin","year":"2024","unstructured":"Yin J-L, Yang J, Song X-J, Qin X, Chang Y-J, Chen X, et al. Triglyceride-glucose index and health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studies. Cardiovasc Diabetol. 2024;23:1\u201318. https:\/\/doi.org\/10.1186\/s12933-024-02241-y.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR42","doi-asserted-by":"publisher","first-page":"11235","DOI":"10.1016\/j.diabres.2025.112354","volume":"226","author":"M Liu","year":"2025","unstructured":"Liu M, Li J, Yan K, Zhang K, Wang M, Guo J, et al. Synergistic interaction and cumulative effect between frailty and triglyceride-glucose index exacerbates cardiovascular disease burden in middle-aged and older adults. Diabetes Res Clin Pract. 2025;226:11235. https:\/\/doi.org\/10.1016\/j.diabres.2025.112354.","journal-title":"Diabetes Res Clin Pract"},{"key":"3191_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.gerinurse.2024.11.011","volume":"61","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Long F, Wu X-T, Lei J, Ma X-Q, Luan X-Y. Dose-response relationship between the age at diagnosis of cardiovascular metabolic multimorbidity and cognitive impairment among middle-aged and older adults in China. Geriatr Nurs. 2024;61:311\u20135. https:\/\/doi.org\/10.1016\/j.gerinurse.2024.11.011.","journal-title":"Geriatr Nurs"},{"key":"3191_CR44","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1002\/alz.14091","volume":"20","author":"C Liu","year":"2024","unstructured":"Liu C, Liu R, Tian N, Fa W, Liu K, Wang N, et al. Cardiometabolic multimorbidity, peripheral biomarkers, and dementia in rural older adults: the MIND-China study. Alzheimers Dement. 2024;20:6133\u201345. https:\/\/doi.org\/10.1002\/alz.14091.","journal-title":"Alzheimers Dement"},{"key":"3191_CR45","doi-asserted-by":"publisher","first-page":"100011","DOI":"10.1016\/j.tjfa.2025.100011","volume":"14","author":"R Jones","year":"2025","unstructured":"Jones R, Enogela EM, Ruderman SA, Kitahata MM, Moore R, Jacobson JM, et al. Cardiometabolic disease among frailty phenotype clusters in adults aging with HIV. J Frailty Aging. 2025;14:100011. https:\/\/doi.org\/10.1016\/j.tjfa.2025.100011.","journal-title":"J Frailty Aging"},{"key":"3191_CR46","doi-asserted-by":"publisher","first-page":"igac032","DOI":"10.1093\/geroni\/igac032","volume":"6","author":"S Shakya","year":"2022","unstructured":"Shakya S, Bajracharya R, Ledbetter L, Cary MPJ. The association between cardiometabolic risk factors and frailty in older adults: a systematic review. Innov Aging. 2022;6:igac032. https:\/\/doi.org\/10.1093\/geroni\/igac032.","journal-title":"Innov Aging"},{"key":"3191_CR47","doi-asserted-by":"publisher","first-page":"105171","DOI":"10.1016\/j.archger.2023.105171","volume":"117","author":"S Shakya","year":"2023","unstructured":"Shakya S, Silva SG, McConnell ES, McLaughlin SJ, Cary MPJ. Structural determinants and cardiometabolic typologies related to frailty in community-dwelling older adults. Arch Gerontol Geriatr. 2023;117:105171. https:\/\/doi.org\/10.1016\/j.archger.2023.105171.","journal-title":"Arch Gerontol Geriatr"},{"key":"3191_CR48","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1038\/s41467-019-12716-2","volume":"10","author":"NJW Rattray","year":"2019","unstructured":"Rattray NJW, Trivedi DK, Xu Y, Chandola T, Johnson CH, Marshall AD, et al. Metabolic dysregulation in vitamin E and carnitine shuttle energy mechanisms associate with human frailty. Nat Commun. 2019;10:5027. https:\/\/doi.org\/10.1038\/s41467-019-12716-2.","journal-title":"Nat Commun"},{"key":"3191_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: The China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2012;43:61\u20138. https:\/\/doi.org\/10.1093\/ije\/dys203.","journal-title":"Int J Epidemiol"},{"key":"3191_CR50","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347\u201351. https:\/\/doi.org\/10.1210\/jc.2010-0288.","journal-title":"J Clin Endocrinol Metab"},{"key":"3191_CR51","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/jcsm.13169","volume":"14","author":"D He","year":"2022","unstructured":"He D, Qiu Y, Yan M, Zhou T, Cheng Z, Li J, et al. Associations of metabolic heterogeneity of obesity with frailty progression: results from two prospective cohorts. J Cachexia Sarcopenia Muscle. 2022;14:632\u201341. https:\/\/doi.org\/10.1002\/jcsm.13169.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3191_CR52","doi-asserted-by":"publisher","first-page":"e650","DOI":"10.1016\/s2468-2667(20)30113-4","volume":"5","author":"J Fan","year":"2020","unstructured":"Fan J, Yu C, Guo Y, Bian Z, Sun Z, Yang L, et al. Frailty index and all-cause and cause-specific mortality in Chinese adults: a prospective cohort study. Lancet Public Health. 2020;5:e650\u201360. https:\/\/doi.org\/10.1016\/s2468-2667(20)30113-4.","journal-title":"Lancet Public Health"},{"key":"3191_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-025-02919-x","volume":"24","author":"L Lv","year":"2025","unstructured":"Lv L, Zhang P, Chen X, Gao Y. The association between triglyceride glucose-waist height ratio index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study. Cardiovasc Diabetol. 2025;24:1\u201313. https:\/\/doi.org\/10.1186\/s12933-025-02919-x.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR54","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jclinepi.2010.10.011","volume":"64","author":"RA Burns","year":"2011","unstructured":"Burns RA, Butterworth P, Kiely KM, Bielak AAM, Luszcz MA, Mitchell P, et al. Multiple imputation was an efficient method for harmonizing the mini-mental state examination with missing item-level data. J Clin Epidemiol. 2011;64:787\u201393. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.10.011.","journal-title":"J Clin Epidemiol"},{"key":"3191_CR55","doi-asserted-by":"publisher","first-page":"228","DOI":"10.7326\/m16-2472","volume":"167","author":"S-Y Park","year":"2017","unstructured":"Park S-Y, Freedman ND, Haiman CA, Le Marchand L, Wilkens LR, Setiawan VW. Association of coffee consumption with total and cause-specific mortality among nonwhite populations. Ann Intern Med. 2017;167:228\u201335. https:\/\/doi.org\/10.7326\/m16-2472.","journal-title":"Ann Intern Med"},{"key":"3191_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-025-02689-6","volume":"24","author":"M-Y Tan","year":"2025","unstructured":"Tan M-Y, Zhang Y-J, Zhu S-X, Wu S, Zhang P, Gao M. The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0\u20133 of cardiovascular\u2013kidney\u2013metabolic syndrome: evidence from two cohort studies. Cardiovasc Diabetol. 2025;24:137. https:\/\/doi.org\/10.1186\/s12933-025-02689-6.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR57","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41746-025-01905-7","volume":"8","author":"C Lu","year":"2025","unstructured":"Lu C, Wan S, Liu Z. Determinants of depressive symptoms in multinational middle-aged and older adults. npj Digit Med. 2025;8:501. https:\/\/doi.org\/10.1038\/s41746-025-01905-7.","journal-title":"npj Digit Med"},{"key":"3191_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-024-02278-z","volume":"23","author":"C Diabetology","year":"2024","unstructured":"Diabetology C, Xu Z, Li J, Liu L. Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults. Cardiovasc Diabetol. 2024;23:1\u201310. https:\/\/doi.org\/10.1186\/s12933-024-02278-z.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR59","doi-asserted-by":"publisher","first-page":"e70025","DOI":"10.1002\/edm2.70025","volume":"8","author":"SS Soflaei","year":"2025","unstructured":"Soflaei SS, Salehi\u2010Sangani P, Fallahi Z, Imanparast F, Marousi M, Tajfard M, et al. Triglyceride\u2010glucose index association with severity of coronary artery disease. Endocrinol Diabetes Metab. 2025;8:e70025. https:\/\/doi.org\/10.1002\/edm2.70025.","journal-title":"Endocrinol Diabetes Metab"},{"key":"3191_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-023-02002-3","volume":"22","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Chen S, Lin C, Huang X, Lin S, Huang F, et al. Association of triglyceride-glucose index trajectory and frailty in urban older residents: evidence from the 10-year follow-up in a cohort study. Cardiovasc Diabetol. 2023;22:1\u201312. https:\/\/doi.org\/10.1186\/s12933-023-02002-3.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR61","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12967-023-04159-7","volume":"21","author":"M Kuang","year":"2023","unstructured":"Kuang M, Yang R, Huang X, Wang C, Sheng G, Xie G, et al. Assessing temporal differences in the predictive power of baseline TyG-related parameters for future diabetes: an analysis using time-dependent receiver operating characteristics. J Transl Med. 2023;21:299. https:\/\/doi.org\/10.1186\/s12967-023-04159-7.","journal-title":"J Transl Med"},{"key":"3191_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12933-025-02597-9","volume":"24","author":"H Tian","year":"2025","unstructured":"Tian H, Li Y, Wang C, Chen G, Lian Y. Association between non-insulin-based insulin resistance indicators and frailty progression: a national cohort study and Mendelian randomization analysis. Cardiovasc Diabetol. 2025;24:31. https:\/\/doi.org\/10.1186\/s12933-025-02597-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR63","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-022-01606-5","volume":"21","author":"X Wang","year":"2022","unstructured":"Wang X, Xu W, Song Q, Zhao Z, Meng X, Xia C, et al. Association between the triglyceride\u2013glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21:168. https:\/\/doi.org\/10.1186\/s12933-022-01606-5.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR64","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12933-023-02055-4","volume":"22","author":"C Cui","year":"2023","unstructured":"Cui C, Liu L, zhang T, Fang L, Mo Z, Qi Y, et al. Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2023;22:325. https:\/\/doi.org\/10.1186\/s12933-023-02055-4.","journal-title":"Cardiovasc Diabetol"},{"key":"3191_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-024-02373-1","volume":"23","author":"K Guo","year":"2024","unstructured":"Guo K, Wang Q, Zhang L, Qiao R, Huo Y, Jing L, et al. Relationship between changes in the triglyceride glucose-body mass index and frail development trajectory and incidence in middle-aged and elderly individuals: a national cohort study. Cardiovasc Diabetol. 2024;23:1\u201316. https:\/\/doi.org\/10.1186\/s12933-024-02373-1.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03191-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03191-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03191-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:31:57Z","timestamp":1786577517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03191-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3191"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03191-3","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,3]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CHARLS was conducted in compliance with the Declaration of Helsinki and approved by the Peking University Institutional Review Board (IRB00001052-11015). All participants provided written informed consent prior to enrollment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"231"}}